Clear Perspective Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$1.13M Sell
19,138
-3,404
-15% -$169K 0.34% 56
2021
Q3
$970K Buy
22,542
+2,190
+11% +$97K 0.33% 57
2021
Q2
$797K Buy
20,352
+3,294
+19% +$128K 0.28% 63
2021
Q1
$618K Buy
17,058
+4,426
+35% +$157K 0.24% 76
2020
Q4
$465K Buy
12,632
+1,566
+14% +$57.4K 0.19% 92
2020
Q3
$581 Buy
11,066
+1,128
+11% +$39.5K 0.27% 68
2020
Q2
$308K Buy
9,938
+1,765
+22% +$60K 0.17% 94
2020
Q1
$253K Buy
8,173
+580
+8% +$19.8K 0.17% 97
2019
Q4
$282K Sell
7,593
-5,797
-43% -$206K 0.17% 112
2019
Q3
$456K Hold
13,390
0.21% 90
2019
Q2
$550K Sell
13,390
-2,412
-15% -$95.8K 0.35% 68
2019
Q1
$613K Buy
15,802
+211
+1% +$8.45K 0.43% 66
2018
Q4
$646K Hold
15,591
0.54% 56
2018
Q3
$652K Sell
15,591
-537
-3% -$20.7K 0.48% 63
2018
Q2
$555K Sell
16,128
-516
-3% -$17.6K 0.39% 75
2018
Q1
$560K Buy
16,644
+47
+0.3% +$1.62K 0.42% 71
2017
Q4
$570K Hold
16,597
0.44% 62
2017
Q3
$562K Buy
+16,597
New +$533K 0.46% 58
2017
Q2
Sell
-15,912
Closed -$502K 59
2017
Q1
$516K Sell
15,912
-6,851
-30% -$216K 0.34% 63
2016
Q4
$701K Buy
+22,763
New +$695K 0.47% 49

Other funds holding PFE

Clear Perspective Advisors's PFE Position: Q4 2021 in Review

Clear Perspective Advisors reduced its Pfizer (PFE) stake by 15% in Q4 2021, selling an estimated $169K and leaving 19,138 shares worth $1.13M. The position accounts for 0.34% of the portfolio, ranked #56.

Clear Perspective Advisors first reported a position in PFE in Q4 2016 and has held it in 20 quarters since. 3,263 funds tracked by Wall St. Rank hold PFE as of Q4 2021.

  • Clear Perspective Advisors held 19,138 shares of Pfizer worth $1.13M as of Q4 2021.
  • Clear Perspective Advisors sold 3,404 Pfizer shares in Q4 2021, an estimated $169K.
  • Pfizer made up 0.34% of Clear Perspective Advisors's portfolio in Q4 2021, its #56 holding.
  • Clear Perspective Advisors first reported a position in Pfizer in Q4 2016 and has held it in 20 quarters since.
  • 3,263 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.

Based on Clear Perspective Advisors's 13F filing for Q4 2021, filed 17 Feb 2022.